Gangolli Julian S
Insider CIK 1532023 · GWPH President, North America · RVNC Director · OTLK Director · KRYS Director · AGN CVP & Pres, North America
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 471 | — | $0 | 471 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 1,187 | — | $0 | 1,187 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 471 | — | $0 | 471 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 1,187 | — | $0 | 1,187 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 286,734 | — | $0 | 286,734 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2025-06-30 | 2025-06-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 15,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 30,106 | $3.65 | $109.9K | 15,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 71,169 | — | $0 | 71,169 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 56,636 | — | $0 | 56,636 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2024-06-30 | 2024-07-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise deriv | 2024-05-20 | 2024-05-22 | 20,000 | — | $0 | 0 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise | 2024-05-20 | 2024-05-22 | 20,000 | $22.75 | $455.0K | 20,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2024-05-20 | 2024-05-22 | 1,980 | $165.76 | $328.2K | 0 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2024-05-20 | 2024-05-22 | 7,090 | $164.34 | $1.17M | 1,980 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2024-05-20 | 2024-05-22 | 10,930 | $163.71 | $1.79M | 9,070 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 23,458 | — | $0 | 23,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-05-01 | 2024-05-03 | 15,000 | — | $0 | 45,106 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 94,441 | — | $0 | 94,441 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-10-04 | 2023-10-06 | 370,282 | — | $0 | 370,282 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2023-06-30 | 2023-07-03 | 6,800 | — | $0 | 6,800 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 5,915 | — | $0 | 5,915 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-05-03 | 2023-05-05 | 3,534 | — | $0 | 30,106 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 41,065 | — | $0 | 41,065 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-10-05 | 2022-10-07 | 74,398 | — | $0 | 74,398 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2022-06-30 | 2022-07-01 | 6,800 | — | $0 | 6,800 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-06 | 11,343 | — | $0 | 11,343 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-13 | 10,756 | — | $0 | 10,756 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-05-04 | 2022-05-06 | 6,059 | — | $0 | 26,572 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-03-23 | 2022-03-24 | 21,878 | — | $0 | 21,878 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2021-10-05 | 2021-10-07 | 44,466 | — | $0 | 44,466 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2021-06-30 | 2021-07-02 | 6,800 | — | $0 | 6,800 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-05-05 | 2021-05-07 | 7,551 | — | $0 | 7,551 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-05-05 | 2021-05-07 | 4,013 | — | $0 | 20,513 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2021-03-24 | 2021-03-26 | 20,873 | — | $0 | 20,873 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-05 | 2020-10-05 | 150,748 | $0.51 | $76.9K | 150,748 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-07-01 | 2020-07-06 | 35,006 | $0.99 | $34.7K | 35,006 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2020-06-30 | 2020-08-07 | 6,800 | — | $0 | 6,800 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-05-14 | 2020-05-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-05-14 | 2020-05-15 | 6,000 | — | $0 | 16,500 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-04-20 | 2020-04-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-10 | 2019-05-14 | 10,788 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-10 | 2019-05-14 | 192,755 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-10 | 2019-05-14 | 6 | — | $0 | 10,603 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-10 | 2019-05-14 | 27,419 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-10 | 2019-05-14 | 365,591 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-10 | 2019-05-14 | 75,369 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 145,164 | $14.96 | $2.17M | 160,752 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 65,268 | $14.80 | $966.0K | 514,176 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 81,156 | $14.70 | $1.19M | 579,444 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 117,876 | $14.63 | $1.72M | 660,600 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 208,260 | $14.88 | $3.10M | 305,916 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-05-10 | 2019-05-14 | 192,755 | $3.72 | $717.0K | 778,476 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 12,048 | $15.03 | $181.1K | 148,704 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 31,368 | $15.12 | $474.3K | 117,336 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-10 | 2019-05-14 | 10,788 | $15.19 | $163.9K | 106,548 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-05-10 | 2019-05-14 | 403,804 | — | $0 | 510,352 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-05-10 | 2019-05-14 | 75,369 | $10.61 | $799.7K | 585,721 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-05-09 | 2019-05-10 | 4,500 | — | $0 | 10,500 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2019-03-01 | 2019-03-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-02-26 | 2019-02-28 | 11,256 | — | $0 | 6 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-26 | 2019-02-28 | 5,952 | $12.45 | $74.1K | 106,596 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-02-26 | 2019-02-28 | 11,256 | — | $0 | 112,548 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-26 | 2019-02-28 | 48 | $12.37 | $594 | 106,548 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-05-10 | 2018-05-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-05-10 | 2018-05-11 | 3,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-05-11 | 2017-05-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-05-11 | 2017-05-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-07-01 | 2016-07-06 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 60,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 15,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 20,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 38,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 52,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 12,500 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 40,729 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 40,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 220 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2015-03-17 | 2015-03-19 | 7,892 | — | $0 | 7,946 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 7,946 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 265 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2015-03-06 | 2015-03-19 | 20,078 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2015-03-06 | 2015-03-19 | 2,095 | — | $0 | 54 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2015-02-20 | 2015-02-24 | 514 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2015-02-20 | 2015-02-24 | 514 | — | $0 | 514 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2015-02-20 | 2015-02-24 | 514 | — | $0 | 2,418 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2015-02-20 | 2015-02-24 | 269 | $234.00 | $62.9K | 2,149 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2015-02-17 | 2015-02-19 | 1,150 | $230.15 | $264.7K | 1,904 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2014-03-06 | 2014-03-07 | 3,120 | — | $0 | 20,054 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2014-03-06 | 2014-03-07 | 3,120 | — | $0 | 3,051 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2014-02-21 | 2014-02-25 | 40,729 | $125.07 | $5.09M | 40,729 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2014-02-21 | 2014-02-25 | 1,880 | $125.07 | $235.1K | 6,171 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-12-27 | 2013-12-30 | 37,500 | — | $0 | 12,500 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2013-12-27 | 2013-12-30 | 15,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-12-27 | 2013-12-30 | 15,000 | $40.16 | $602.4K | 23,047 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-12-27 | 2013-12-30 | 37,500 | $110.00 | $4.13M | 8,047 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2013-12-27 | 2013-12-30 | 15,000 | $110.17 | $1.65M | 8,047 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2013-12-27 | 2013-12-30 | 37,500 | $59.13 | $2.22M | 45,547 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2013-02-28 | 2013-03-04 | 4,301 | — | $0 | 16,874 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2013-02-28 | 2013-03-04 | 4,301 | — | $0 | 8,035 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2013-02-21 | 2013-02-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2013-02-21 | 2013-02-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2013-02-20 | 2013-02-22 | 2,699 | $108.08 | $291.7K | 12,336 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2013-01-11 | 2013-01-14 | 401 | — | $0 | 12,573 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2013-01-11 | 2013-01-14 | 401 | — | $0 | 15,027 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-12-31 | 2013-01-03 | 202 | $91.73 | $18.5K | 15,579 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-12-31 | 2013-01-03 | 151 | $91.73 | $13.9K | 15,428 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-11-28 | 2012-11-29 | 55,378 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-11-28 | 2012-11-29 | 55,378 | $91.66 | $5.08M | 15,781 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-11-28 | 2012-11-29 | 55,378 | $58.55 | $3.24M | 71,159 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-11-27 | 2012-11-29 | 4,622 | — | $0 | 55,378 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-11-27 | 2012-11-29 | 30,000 | — | $0 | 15,000 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-11-27 | 2012-11-29 | 30,000 | $40.16 | $1.20M | 50,403 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-11-27 | 2012-11-29 | 34,622 | $92.25 | $3.19M | 15,781 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-11-27 | 2012-11-29 | 4,622 | $58.55 | $270.6K | 20,403 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2012-03-15 | 2012-03-19 | 345 | — | $0 | 15,755 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2012-03-15 | 2012-03-19 | 345 | — | $0 | 12,172 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-02-22 | 2012-02-24 | 157 | $87.27 | $13.7K | 16,100 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-02-17 | 2012-02-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-02-17 | 2012-02-22 | 38,000 | — | $0 | 38,000 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2012-02-17 | 2012-02-22 | 323 | — | $0 | 16,257 | SEC↗ |